Premier Inc. Partners with HealthVerity to Enhance Access to Real-World Data for Life Sciences Research

Reuters
2025/05/13
<a href="https://laohu8.com/S/PINC">Premier Inc.</a> Partners with HealthVerity to Enhance Access to Real-World Data for Life Sciences Research

Premier Inc. has announced a new partnership with HealthVerity, integrating their extensive healthcare data into the HealthVerity Marketplace. This collaboration aims to expand real-world data access for life sciences research, providing high-value datasets, including chargemaster, laboratory results, and EMR data. The integration will enable life sciences organizations to accelerate clinical and commercial insights, supporting research across the product lifecycle. Premier's comprehensive data, including the Premier® Healthcare Database, will offer researchers the ability to analyze drug and device utilization with greater specificity and generate insights into care quality, safety, and cost. This partnership is expected to add substantial value for pharmaceutical manufacturers and healthcare innovators, strengthening study design and enhancing therapeutic advancements.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Premier Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: PH85423) on May 13, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10